Skip to content

Clinical trials

Observational Stroke trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Observational Country / region: Hong Kong Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20132
20141
20151
20171
20182
20193
20204
20211
20223
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting5
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong12
The University of Hong Kong2
Bayer1
Boehringer Ingelheim1
Hospital Authority, Hong Kong1
Population Health Research Institute1
Tai Po Hospital1
The Hong Kong Polytechnic University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke20
Ischemic Stroke8
Brain Diseases4
Atrial Fibrillation3
Myocardial Infarction3
Alzheimer Disease2
Atherosclerosis2
Brain Ischemia2
Dementia2
Intracranial Arteriosclerosis2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.